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Hemodiafiltration with online regeneration of the ultrafiltrate. technique. Different techniques either increase diffusion
The concept of regeneration of dialysis fluids and of ultrafiltrate (high dialyzer surfaces) or convection (high ultrafiltration
in particular has been recently revisited. Hemodiafiltration with rates, high infusion volumes). From renal physiology,online regeneration of the ultrafiltrate allows the concomitant
urine formation begins with the filtration (convection) ofinfusion of sodium, calcium, and bicarbonate. Here, we studied
essentially protein-free plasma through the glomerular cap-the adsorptive characteristics of an integrated two-step sorbent
system relative to different solutes present in the ultrafiltrate: illaries. The final urine is quite different from the glomeru-
sodium, calcium, phosphate, bicarbonate, uric acid, creatinine, lar filtrate because, as the fluid flows through the tubule,
and b2-microglobulin. In vitro studies were performed in order its composition is altered by tubular reabsorption andto differentiate the relative roles for each sorbent (mineral-acti-
tubular secretion. Historically, many attempts to mimicvated charcoal or hydrophobic resin) in adsorbing a given solute.
the renal function have been suggested using regenera-Ex vivo studies were performed in order to evaluate the pres-
ence of cytokines (interleukin-1b and tumor necrosis factor-a), tion of the dialysate or the ultrafiltrate by dialysis [1, 2],
of cytokine (interleukin-1b and tumor necrosis factor-a)-induc- by other physical-chemical treatments [3] or by sorbents
ing activities, and of the cytokine release in response to exoge- [4, 5]. However, none of the proposed schemes for dial-nous bacterial lipopolysaccharide by normal whole blood incu-
ysis fluid regeneration has become an established tech-bated with ultrafiltrate samples obtained at 15, 120, and 240
nique, with the exception of the double-chamber hemo-minutes after the start of treatment. The results of the present
studies show the presence of immunomodulatory substances diafiltration, named as paired filtration dialysis (PFD) [6].
in the ultrafiltrate and the significant (P , 0.01) increase in Even recently, sorbents are still described in the chapter
the lipopolysaccharide-induced release of both interleukin-1b
of hemoperfusion, historically the first but not the onlyand tumor necrosis factor-a. The biological relevance of the
dialysis method [7]. The reader is invited to refer to theultrafiltrate and the possible relevance of the online, endoge-
nous reinfusion are discussed. review on the historical landmarks of sorbents in hemo-
dialysis by Botella and Sanz-Moreno in this issue [8].
In this study, we report on investigations aiming at
There are over 320,000 patients with chronic kidney the in vitro and ex vivo evaluation of the adsorptive
failure in the United States and approximately one mil- properties of a new integrated sorbent system.
lion worldwide. The majority are kept alive by hemodial-
ysis to purify their blood of toxins and excess fluid. Al-
METHODSthough hemodialysis is a life-saving procedure, it does
In vitro experimentsnot completely replace a functioning kidney. People on
dialysis still suffer from a variety of problems, including Pure ultrafiltrate (approximately 12 L) was collected
chronic joint and back pain, nerve compression, anemia, from 10 end-stage renal disease (ESRD) patients under-
chronic malnutrition, vascular complications, depressed going PFD and was pooled and stored at 2208C. On the
immune system, and a drastically shortened lifespan. day of the experiment, the ultrafiltrate was placed in a
Medicare, which covers 70 to 80% of U.S. dialysis ex- reservoir under continuous stirring and constant tempera-
penses, pays over six billion dollars annually on these ture (378C) and was pumped (50 mL/min) through a two-
and related health problems in dialysis patients. cartridge system, one containing activated mineral char-
Hemodialysis is still entirely a “removing”/“replacing” coal (120 mL) and the other a hydrophobic styrenic resin
(60 mL). In condition I, the “charcoal” preceded the
“resin” cartridge, whereas the inverse order was used inKey words: biocompatibility, infusion, sterility, dialysate, two-step sor-
bent system, immunomodulation, chronic renal failure. condition II. Samples were taken before the cartridge sys-
tem (“pre”), between the two cartridges (“intermediate”),Ó 2000 by the International Society of Nephrology
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Moelndal, Sweden), tumor necrosis factor-a (TNF-a),
and interleukin-1b (IL-1b; by specific immunoassay,
Quantikine; R&D Systems), and by their capacity to
induce cytokine (TNFa and IL-1b) synthesis and release
from whole blood [9]. Fresh heparinized blood, obtained
from normal healthy volunteers, diluted 1:2 with RPMI
1640 (Sigma Chemical Co., St. Louis, MO, USA), and
dispensed (0.5 mL) in sterile polyethylene tubes was
incubated (6 h, 378C, 5% CO2) in the presence of ultrafil-
trate samples (0.5 mL), and as controls, ultrapure iso-
tonic saline (0.5 mL, negative control) and ultrapure
isotonic saline were added with bacterial lipopolysaccha-
ride (LPS; 10 ng/mL, final concentration, from Esche-
richia coli, 055:B5; Sigma). To study the presence of LAL-
unreactive, lipid-A–containing fragments, polimyxin B
(13.3 mg/mL, final concentration; Sigma), a neutralizing
ligand for the lipid A moiety of endotoxin, was preincu-
bated with the ultrafiltrate samples. The mixture was
added to the whole blood and treated as described pre-
viously in this article. To test the effect of ultrafiltrate
samples on the LPS response by normal leukocytes, whole
Fig. 1. Schematic drawing of the hemodiafiltration with online regener- blood was incubated (6 hours, 378C, 5% CO2) with ultra-
ation of the ultrafiltrate (uf). filtrate samples (precartridge and postcartridge) and LPS
at a fixed final concentration of 10 ng/mL. At the end
of the incubation period, whole blood was lyzed with
Triton X (final concentration: 0.5%, BDH Chemicalsand after the system (“post”). The following determina-
Ltd., Poole, UK) and tested for TNF-a and IL-1b.tions were performed: creatinine, urea, glucose, phos-
phate, calcium, sodium, potassium, uric acid, and b2-micro-
globulin. Creatinine, uric acid, urea, glucose, phosphate, RESULTS
calcium, sodium, and potassium were assessed by con- In vitro experiments
ventional laboratory methods. b2-Microglobulin was as- Figure 2 schematically depicts the two conditions (I
sessed by a specific immunoassay (R&D Systems, Minne-
and II) used to assess the adsorptive characteristics of
apolis, MN, USA). Ultrafiltrable, low-molecular-weight the two types of sorbents. In condition I, the charcoal
uremic toxins were qualitatively assessed by reverse-phase appeared to remove creatinine efficiently (Fig. 2A) with
high-pressure liquid chromatography using an Econosil a percentage of 76 6 23 between intermediate and pre-
C18 5 m column (Altech, Palo Alto, CA, USA) in formic cartridge samples (mean 6 1 SD). The resin added some
acid 0.05 mol/L, pH 4, with a gradient from 0 to 100% adsorptive effect, which led to a final percentage of 82 6
in methyl alcohol for 45 minutes and isocratically up to 18% between postcartridge and intermediate samples.
52 minutes. The injection volume was 20 mL. The resin was, however, inefficient in adsorptive creati-
nine, especially in the presence of high concentrations.Ex vivo studies
As studied in condition II (Fig. 2B), the resin removed
Twelve ESRD patients were selected for this study. only 19 6 30% (intermediate and precartridge samples),
They had been on hemodialysis for at least six months. while the charcoal reconfirmed its capacity to adsorb
PFD was performed with a double-chamber hemodia- large amounts of creatinine (percentage of removal be-
lyzer composed of a convective filter (polysulfone, 0.5 m2), tween postcartridge and intermediate samples, 93 6 6).
followed by a diffusive dialyzer (synthetically modified It was also evident that in condition II, although the
cellulose, 1.95 m2). The ultrafiltrate line was connected charcoal removed high amounts of creatinine, some de-
to a single cartridge composed of a two-step sorbent tectable amounts could be observed (note the SD), which
(mineral-activated charcoal 1 resin, Selectat; Bellco, was not the case in condition I. Similar data were ob-
Mirandola, Italy; Fig. 1). Samples were taken before served for uric acid. Neither the charcoal nor resin ad-
and after the cartridge at 15, 120, and 240 minutes after sorbed the glucose, phosphate, calcium, sodium, and po-
initiation of the session in a sterile manner. Precartridge tassium (Table 1). For b2-microglobulin (condition I; Fig.
and postcartridge samples were tested for endotoxin 2C), while the charcoal adsorbed only a part of the total
b2-microglobulin (removal between postcartridge and in-(LAL test, chromogenic assay; Coatest, Chromogenix,
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Fig. 2. Schematic drawing of conditions I and II. For these in vitro experiments, the charcoal (120 mL) and the resin (20 mL) were placed in two
separate cartridges in order to analyze the relative adsorptive capacities in regard to each given solute. Box whiskers show the concentrations of
creatinine (A and B) and b2-microglobulin (C and D) in samples before the charcoal (condition I) or the resin (condition II; “pre”), in between
the two cartridges (“intermediate”) and after the resin (condition I) or the charcoal (condition II; “post”).
Table 1. Mean concentration in the ultrafiltrate, precharcoal, and Reverse-phase high-pressure liquid chromatography
postcharcoal 1 resin (condition I)
(HPLC) of the ultrafiltrates allowed identification of two
Pre Post P remarkable behaviors (Fig. 3). The charcoal was effective
Glucose mg/dL 99615 85612 NS in adsorbing the ultrafiltrable, low-molecular-weight ure-
HCO3 mEq/L 2662 2762 NS mic peaks. Almost none of the peaks that had beenPhosphate mg/dL 4.760.9 3.760.7 NS
observed at the beginning of the recirculation (Fig. 3A)Calcium mg/dL 6.160.9 660.8 NS
Urea mg/dL 94611 84614 NS could be detected in the tracings of ultrafiltrate samples
K mEq/L 4.560.7 4.560.6 NS obtained after the cartridge at 240 minutes (Fig. 3B).Na mEq/L 14065 13964 NS
However, the resin was absolutely ineffective (Fig. 3 C, D).
Ex vivo studies
The precartridge ultrafiltrate samples contained bothtermediate samples, 40 6 26%), the resin adsorbed it
TNF-a and IL-1b, but in very low concentrations (42 6 12completely in all samples (percentage of removal between
and 12 6 7 pg/mL, respectively), which were completelyintermediate and precartridge samples, 100). The high
removed by the two-step sorbent system. As shown inadsorptive capacity the resin for b2-microglobulin was
Table 2, all precartridge samples at any time intervalsreconfirmed in condition II (Fig. 2D), where the resin
showed detectable TNF-a/IL-1b–inducing activities thatalone could remove almost the total amount of b2-micro-
were not removed after passage through the cartridge.globulin (removal between intermediate and precar-
tridge samples, 99 6 1%). Polimyxin B had almost no effect on IL-1b–inducing
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Fig. 3. High-pressure liquid chromatography tracings of precartridge ultrafiltrate samples at 15 minutes (A and C ) and postcartridge at 240 minutes
(B and D) after passage through the charcoal (B) and the resin (D).
Table 2. Cytokine (IL-1b, IL-1a)-inducing activity (means61 SD) No detectable amounts of LAL-reactive components were
from normal human whole blood incubated with ultrafiltrate
detected in the precartridge or postcartridge ultrafiltratesamples during PFD in 12 ESRD patients, obtained before and after
the two-step sorbent (charcoal 1 resin) system samples by the LAL assay (sensitivity, 0.03 EU/mL).
IL-1b–inducing activity TNF-a–inducing activity
Time
(min) Pre Post Pre Post DISCUSSION
15 63.6634.3 58.2624.2 25.5610.1 19.967.9 The use of ultrafiltrate for sorbent application allows
120 72.2633.8 60.2634.5 27.468.3 25.6613.8 the immediate solution of many complex problems of240 63.1629.2 57.2634.6 29.4616.5 21.7611.5
performance characteristics and hemocompatibility that
are historically well known in hemoperfusion [7]. There-
fore, the adsorptive capacities of the sorbent may be
fully appreciated by using uncoated sorbents. Charcoalactivity (27 and 26% in precartridge and postcartridge
has been the most commonly used sorbent for biomedi-samples, respectively). Polimyxin B induced a marked
cal applications. The results of the present study suggestenhancement of TNF-a–inducing activity (57 and 43%
that charcoal can efficiently remove creatinine, uric acid,in precartridge and postcartridge samples, respectively,
and small molecular weight HPLC “uremic peaks,” butP 5 0.006). The stimulation experiments showed a sig-
has no effect on urea, Na1, Ca1, P2, PO4H1, glucose,nificant increase in TNF-a/IL-1b release in response to
and HCO3. These results are in agreement with andLPS in 10 out of 12 (P 5 0.007; Fig. 4A) and 7 out
extend previously published evidence [5]. Using a two-of 12 patients (P 5 0.004; Fig. 4B), respectively. The
step sorbent system, the addition of the resin was effec-ultrafiltrate samples obtained after the cartridge induced
tive in removing both TNF-a and IL-1b, in keeping witha response to LPS that was not statistical significantly
different in terms of release of both TNF-a and IL-1b. the demonstration of its capacity to remove polypeptides
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Fig. 4. Interleukin-1b (IL-1b) and tumor necrosis factor-a (TNF-a) release from normal human whole blood incubated with lipopolysaccharide
(LPS; Methods section) in the presence of ultrafiltrate samples obtained in patients at 15, 120, and 240 minutes. As positive control (data not
shown), the release of IL-1b and TNF-a in the presence of ultrapure isotonic saline incubated with normal human whole blood challenged with
LPS (10 ng/mL) was 6931 6 65 and 1878 6 0.9 pg/mL, respectively.
[10]. This was probably because of its high hydropho- Further studies are needed to understand better the
mechanisms for these immunomodulatory activities. Thebicity, which could also explain the high adsorptive ca-
pacity for b2-microglobulin. ultrafiltrate is a highly complex solution in which the com-
position encompasses over 20,000 molecular masses repre-The ultrafiltrate stimulated the release of both TNF-a
and IL-1b from normal whole blood. Possible candidates senting native, circulating peptides [15]. Estimation of re-
peatedly detected masses suggests that approximately 5000could be endotoxin (or other lipid A-containing frag-
ments), activated complement components [11], or ara- different species may be recorded (fragments from plasma
proteins, for example, fibrinogen, albumin, b2-microglob-chidonate metabolites such as platelet-activating factor
[12, 13]. The role of endotoxin or other lipid A-con- ulin; peptide hormones, growth factors, and cytokines;
complement factors, enzymes, enzyme inhibitors andtaining fragments were ruled out by the preincubation
of polimyxin B, a known high-affinity ligand of lipid A. transport proteins; and novel peptide precursors) [15].
The ultrafiltrate expresses biological activities such asIn contrast to expectations, TNF-a–inducing activity was
markedly enhanced. We have no explanation for this the capacity of inhibiting the membrane calcium pump
[16], inhibition of monocytes and granulocyte adherencefinding at the moment.
There was no significant change in the previous post- to endothelial cells [17], decreased metabolic response
to phagocytic leukocytes [18], differential expression ofcartridge ultrafiltrate-stimulated cytokine release. How-
ever, it was interesting to note that precartridge samples various cell receptors [19], and decreased synthesis and
release of platelet-activating factor [20]. Finally, the ultra-at 120 and 240 minutes exhibited the capacity to restore
the response to LPS near to normal, which appeared to filtrate contains hydrosoluble “uremic toxins,” particu-
larly of the low-molecular-weight species, which maybe markedly inhibited at the start of the session (15
minutes). Even more relevant was the fact that passage appear as “uremic peaks” by reverse-phase HPLC [21].
The reader is invited to consult the extensive review byof the ultrafiltrate through the sorbent cartridge did not
modify the enhanced response to LPS observed over the Dhondt et al on the uremic toxins in this issue [22]. The
large number of biologically active compounds found insession. It is not clear from these studies whether the
enhanced response to LPS is due to a mere convective the hemofiltrate makes any dialytic approach directed
to its regeneration particularly challenging. At the level“removal” or whether the regenerated ultrafiltrate may
have a role in these immunomodulatory changes. These of anions and cations, this might be of particular rele-
vance. The restitution of ultrafiltered Na1, Ca11, andresults also suggest that the cytokine-inducing activity is
dissociated from the capacity to respond to exogenous HCO32 may insure the subsequent fluid loss in normona-
triemic conditions, the concomitant infusion of Ca11 andLPS. In contrast to what was described by Hoffmann et
al in septic ultrafiltrates, there was no dissociation in the HCO3, and avoid the convective loss of HCO32. The
convective loss of cations such as K1 is impeded. Redaellirelease of TNF-a and IL-1b [14]. The ultrafiltrate from
ESRD patients had a much lower IL-1b–inducing activ- et al elegantly implicated the arrhythmogenic effect of
hemodialysis during K1 removal not only as a markerity, but a similar TNF-inducing activity.
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